Q/C TECHNOLOGIES INC (QCLS) Stock Overview
USA - NASDAQ:QCLS - US62856X2018 - Common Stock
QCLS Key Statistics, Chart & Performance
The current stock price of QCLS is 3.68 USD.
QCLS Latest News, Press Relases and Analysis
QCLS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 51.61 | 788.86B | ||
| JNJ | JOHNSON & JOHNSON | 19.07 | 459.32B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 19.04 | 262.09B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.71 | 252.96B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.69 | 251.72B | ||
| MRK | MERCK & CO. INC. | 11.17 | 214.78B | ||
| PFE | PFIZER INC | 7.31 | 140.89B | ||
| SNY | SANOFI-ADR | 10.95 | 117.20B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.53 | 89.48B | ||
| GSK | GSK PLC-SPON ADR | 9.76 | 87.63B | ||
| ZTS | ZOETIS INC | 22.69 | 62.54B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 48.96 | 43.30B |
Related stock screener links
About QCLS
Company Profile
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The firm is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. Isomyosamine is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. Isomyosamine is being developed to treat diseases and disorders marked by acute or chronic inflammation. Isomyosamine works by regulating the release of numerous pro-inflammatory cytokines. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the CBD market, which includes both Food and Drug Administration (FDA) approved drugs and CBD products not regulated as drugs.
Company Info
Q/C TECHNOLOGIES INC
1185 Avenue Of The Americas, Suite 249
New York City NEW YORK US
Employees: 2
Phone: 18568488698
Q/C TECHNOLOGIES INC / QCLS FAQ
What is the stock price of Q/C TECHNOLOGIES INC today?
The current stock price of QCLS is 3.68 USD. The price decreased by -7.3% in the last trading session.
What is the ticker symbol for Q/C TECHNOLOGIES INC stock?
The exchange symbol of Q/C TECHNOLOGIES INC is QCLS and it is listed on the Nasdaq exchange.
On which exchange is QCLS stock listed?
QCLS stock is listed on the Nasdaq exchange.
What is Q/C TECHNOLOGIES INC worth?
Q/C TECHNOLOGIES INC (QCLS) has a market capitalization of 6.81M USD. This makes QCLS a Nano Cap stock.
How many employees does Q/C TECHNOLOGIES INC have?
Q/C TECHNOLOGIES INC (QCLS) currently has 2 employees.
Should I buy Q/C TECHNOLOGIES INC (QCLS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of QCLS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of QCLS, evaluating the profitability, health, valuation and growth aspects
- Q/C TECHNOLOGIES INC (QCLS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Q/C TECHNOLOGIES INC (QCLS) Sales and EPS estimates to see what analysts future expectations are.
- Q/C TECHNOLOGIES INC (QCLS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Q/C TECHNOLOGIES INC (QCLS) Insider and Institutional Ownership to learn about the owners and their transactions.
- Q/C TECHNOLOGIES INC (QCLS) Stock Chart to make your own analysis
- Q/C TECHNOLOGIES INC (QCLS) Latest news and press-releases to stay up to date.
Does Q/C TECHNOLOGIES INC (QCLS) stock pay dividends?
QCLS does not pay a dividend.
When does Q/C TECHNOLOGIES INC (QCLS) report earnings?
Q/C TECHNOLOGIES INC (QCLS) will report earnings on 2025-11-12.
What is the Price/Earnings (PE) ratio of Q/C TECHNOLOGIES INC (QCLS)?
Q/C TECHNOLOGIES INC (QCLS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-56.09).
QCLS Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to QCLS.
QCLS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to QCLS. While QCLS seems to be doing ok healthwise, there are quite some concerns on its profitability.
QCLS Financial Highlights
Over the last trailing twelve months QCLS reported a non-GAAP Earnings per Share(EPS) of -56.09. The EPS decreased by -449.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -61.38% | ||
| ROE | -90.74% | ||
| Debt/Equity | 0 |